Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Vaccines

Free Subscription 06.05.2024 1 BMC Pediatr 1 BMJ 2 Clin Infect Dis 1 J Immunol 1 J Infect 3 J Infect Dis 2 J Pediatr 3 Lancet 1 Nat Med 5 PLoS One 12 Vaccine 2 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Pediatr

1. OGILVIE RP, Layton JB, Lloyd PC, Jiao Y, et al
   Effectiveness of BNT162b2 COVID-19 primary series vaccination in children aged 5-17 years in the United States: a cohort study.
   BMC Pediatr. 2024;24:276.
   PubMed         Abstract available
   
   

   
   BMJ

2. KMIETOWICZ Z
   MMR uptake in England quadruples in 2024.
   BMJ. 2024;385:q972.
   PubMed        
   
   

   
   Clin Infect Dis

3. JORGENSEN SCJ, Brown K, Clarke AE, Schwartz KL, et al
   The Effect of COVID-19 Vaccination on Outpatient Antibiotic Prescribing in Older Adults: A Self-Controlled Risk-Interval Study.
   Clin Infect Dis. 2024 May 3:ciae182. doi: 10.1093.
   PubMed         Abstract available
   
   
4. 
   Correction to: Impact of Seasonal Coronavirus Antibodies on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responses in Solid Organ Transplant Recipients.
   Clin Infect Dis. 2024 Apr 30:ciae164. doi: 10.1093.
   PubMed        
   
   

   
   J Immunol

5. BUDYLOWSKI P, Chau SLL, Banerjee A, Guvenc F, et al
   A Significant Contribution of the Classical Pathway of Complement in SARS-CoV-2 Neutralization of Convalescent and Vaccinee Sera.
   J Immunol. 2024 Apr 29:ji2300320. doi: 10.4049/jimmunol.2300320.
   PubMed         Abstract available
   
   

   
   J Infect

6. POWELL AA, Dowell AC, Moss P, Ladhani SN, et al
   Current state of COVID-19 in children: 4 years on.
   J Infect. 2024 Mar 1:106134. doi: 10.1016/j.jinf.2024.106134.
   PubMed         Abstract available
   
   

   
   J Infect Dis

7. BI Q, Dickerman BA, Nguyen HQ, Martin ET, et al
   Reduced effectiveness of repeat influenza vaccination: distinguishing among within-season waning, recent clinical infection, and subclinical infection.
   J Infect Dis. 2024 Apr 30:jiae220. doi: 10.1093.
   PubMed         Abstract available
   
   
8. JUHL AK, Lokso Dietz L, Schmeltz Sogaard O, Reekie J, et al
   Longitudinal evaluation of SARS-CoV-2 T cell immunity over 2 years following vaccination and infection.
   J Infect Dis. 2024 Apr 30:jiae215. doi: 10.1093.
   PubMed         Abstract available
   
   
9. SIRIVICHAYAKUL C, Biswal S, Saez-Llorens X, Lopez-Medina E, et al
   Efficacy and Safety of a Tetravalent Dengue Vaccine (TAK-003) in Children With Prior Japanese Encephalitis or Yellow Fever Vaccination.
   J Infect Dis. 2024 Apr 29:jiae222. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Pediatr

10. ZENG M, Ma WJ
    Reply to the Letter to the Editor regarding cross-protection of RotaTeq.
    J Pediatr. 2024;268:113953.
    PubMed        
    
    
11. CARIAS C, Hartwig S, Kanibir N, Matthijnssens J, et al
    Letter to the Editor on Cross-Protection of RotaTeq.
    J Pediatr. 2024;268:113952.
    PubMed        
    
    

    
    Lancet

12. COULBORN RM, Danet C, Alsalhani A
    Measles and rubella vaccine microneedle patch: new hope to reach the unreached children.
    Lancet. 2024 Apr 29:S0140-6736(24)00749-9. doi: 10.1016/S0140-6736(24)00749.
    PubMed        
    
    
13. ADIGWEME I, Yisa M, Ooko M, Akpalu E, et al
    A measles and rubella vaccine microneedle patch in The Gambia: a phase 1/2, double-blind, double-dummy, randomised, active-controlled, age de-escalation trial.
    Lancet. 2024 Apr 29:S0140-6736(24)00532-4. doi: 10.1016/S0140-6736(24)00532.
    PubMed         Abstract available
    
    
14. ADEPOJU P
    Moderna stalls on African vaccine manufacturing plans.
    Lancet. 2024;403:1617.
    PubMed        
    
    

    
    Nat Med

15. ZHONG Y, Kang AYH, Tay CJX, Li HE, et al
    Correlates of protection against symptomatic SARS-CoV-2 in vaccinated children.
    Nat Med. 2024 Apr 30. doi: 10.1038/s41591-024-02962.
    PubMed         Abstract available
    
    

    
    PLoS One

16. JOHN FA, Criollo V, Gaghan C, Armwood A, et al
    Immunization of turkeys with Clostridium septicum alpha toxin-based recombinant subunit proteins can confer protection against experimental Clostridial dermatitis.
    PLoS One. 2024;19:e0302555.
    PubMed         Abstract available
    
    
17. JANNAT Z, Das H, Ali MW, Wahed T, et al
    Disparities in COVID-19 vaccine uptake among rural hard-to-reach population and urban high-risk groups of Bangladesh.
    PLoS One. 2024;19:e0302056.
    PubMed         Abstract available
    
    
18. HWANG LA, Vaithilingam S, Ng JWJ, Nair M, et al
    The continuance intention to vaccinate against COVID-19: An empirical study from Malaysia.
    PLoS One. 2024;19:e0301383.
    PubMed         Abstract available
    
    
19. YAMAJI T, Harada T, Hashimoto Y, Nakano Y, et al
    Effects of BNT162b2 mRNA Covid-19 vaccine on vascular function.
    PLoS One. 2024;19:e0302512.
    PubMed         Abstract available
    
    
20. TAMARGO JA, Martin HR, Diaz-Martinez J, Delgado-Enciso I, et al
    Drug use and COVID-19 testing, vaccination, and infection among underserved, minority communities in Miami, Florida.
    PLoS One. 2024;19:e0297327.
    PubMed         Abstract available
    
    

    
    Vaccine

21. DORJEE K, Namdon T, Topgyal S, Gyatso U, et al
    Association between Covishield vaccine and menstrual disturbance. Findings from a cross-sectional study among participants of Zero TB cohort in India.
    Vaccine. 2024 Apr 27:S0264-410X(24)00500-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
22. EJNAR HANSEN M, David Pickering S
    The role of religion and COVID-19 vaccine uptake in England.
    Vaccine. 2024;42:3215-3219.
    PubMed         Abstract available
    
    
23. MUTTUCUMARU R, Lau CL, Leeb A, Mills DJ, et al
    Post-marketing surveillance of 10,392 herpes zoster vaccines doses in Australia.
    Vaccine. 2024;42:3166-3171.
    PubMed         Abstract available
    
    
24. PIASECKI AM, Hall DM, Zajac J, Miller SA, et al
    A programmatic update on COVID-19 vaccination in rural communities in the United States.
    Vaccine. 2024 Apr 25:S0264-410X(24)00469-9. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
25. LUO G, Zeng Y, Sheng R, Zhang Z, et al
    Wa-VP4* as a candidate rotavirus vaccine induced homologous and heterologous virus neutralizing antibody responses in mice, pigs, and cynomolgus monkeys.
    Vaccine. 2024 Apr 25:S0264-410X(24)00483-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
26. XIE Z, Stallings-Smith S, Patel S, Case S, et al
    COVID-19 booster vaccine uptake and reduced risks for long-COVID: A cross-sectional study of a U.S. adult population.
    Vaccine. 2024 Apr 25:S0264-410X(24)00509-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
27. LYTRAS T, Athanasiadou M, Demetriou A, Stylianou D, et al
    Authors' reply: Excess mortality in Cyprus during the COVID-19 vaccination campaign.
    Vaccine. 2024 Apr 25:S0264-410X(24)00506-1. doi: 10.1016/j.vaccine.2024.
    PubMed        
    
    
28. GUDOORU K, Nguyen K, Le K, Sarabu V, et al
    Collective good and individual choice: Perceptions on COVID-19 vaccine mandate among COVID-19 vaccinated individuals.
    Vaccine. 2024 Apr 27:S0264-410X(24)00479-1. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
29. NIESSEN FA, Bruijning-Verhagen PCJL, Bonten MJM, Knol MJ, et al
    Vaccine effectiveness against COVID-19 related hospital admission in the Netherlands by medical risk condition: A test-negative case-control study.
    Vaccine. 2024 Apr 29:S0264-410X(24)00432-8. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
30. FLEARY SA, Shahn Z, Teasdale CA
    Effects of parental childhood cultural health environment on children's influenza and COVID-19 vaccination status.
    Vaccine. 2024 Apr 29:S0264-410X(24)00515-2. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
31. MASTROLEO I
    Use of experimental vaccines is ethically permissible during public health emergencies.
    Vaccine. 2024 May 1:S0264-410X(24)00504-8. doi: 10.1016/j.vaccine.2024.
    PubMed        
    
    
32. JI W, Zhou H, Li J, Britto CD, et al
    Distributions of candidate vaccine Targets, virulence Factors, and resistance features of invasive group B Streptococcus using Whole-Genome Sequencing: A Multicenter, population-based surveillance study.
    Vaccine. 2024 Apr 30:S0264-410X(24)00498-5. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    

    
    Virology

33. MA X, Wang Q, Xu X, Zhang W, et al
    miR-214-PTEN pathway is a potential mechanism for stress-induced immunosuppression affecting chicken immune response to avian influenza virus vaccine.
    Virology. 2024;595:110094.
    PubMed         Abstract available
    
    
34. KIM KH, Bhatnagar N, Subbiah J, Liu R, et al
    Cross-protection against influenza viruses by chimeric M2e-H3 stalk protein or multi-subtype neuraminidase plus M2e virus-like particle vaccine in ferrets.
    Virology. 2024;595:110097.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.